688513.SS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 Jun 2024 @ 02:42):

Stats
Today's Volume	596 102
Average Volume	444 249
Market Cap	6.57B
EPS	CNY0 ( 2024-05-20 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	27.21
ATR14	CNY0.144 (0.26%)

Volume Correlation

Long: -0.25 (neutral)

Short: 0.64 (weak)

Signal:(40.226) Neutral

Chengdu Easton Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Chengdu Easton Correlation - Currency/Commodity

-0.36
( neutral )

-0.40
( neutral )

0.00
( neutral )

0.69
( moderate )

0.60
( weak )

Chengdu Easton Financials

Annual	2023
Revenue:	CNY1.12B
Gross Profit:	CNY893.36M (80.00 %)
EPS:	CNY1.880

FY	2023
Revenue:	CNY1.12B
Gross Profit:	CNY893.36M (80.00 %)
EPS:	CNY1.880

FY	2023
Revenue:	CNY0
Gross Profit:	CNY0 (0.00 %)
EPS:	CNY0

FY	2022
Revenue:	CNY1.17B
Gross Profit:	CNY974.51M (83.25 %)
EPS:	CNY2.05

Financial Reports:

No articles found.

Chengdu Easton Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Chengdu Easton

Chengdu Easton Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms in anesthetic/analgesics, cardiovascular, oncology, pediatrics, and other therapeutic fields. It also offers active pharmaceutical ingredients in oncology, cardiovascular, anesthetic/analgesics, anti-inflammatory, gastrointestinal, antiemetic, neurology/psychiatry , and urinary system therapeutic categories. The company was founded in 2009 and is based in Chengdu, China.